Two University College Dublin spin-out companies, Celtic Catalysts and Equinome, both headquartered at NovaUCD, have been shortlisted for the Irish Times/InterTradeIreland 2011 Innovation Awards.
Now in its second year, the Awards were established by the Irish Times and InterTradeIreland to acknowledge the people who drive innovation in their organisations, either indigenous or international companies (small, medium or large), who are operating throughout the island of Ireland to promote service, product or operational innovation. From over 100 entries, 21 companies have been shortlisted in seven award categories.
Celtic Catalysts, a venture capital-backed life sciences company, has developed ground-breaking chemistry that enables its end user clients in the pharmaceutical, biotech and fine chemicals industries to realise significant manufacturing cost savings. Celtic Catalysts was co-founded in 2000 by Professor Declan Gilheany and Dr Brian Kelly as a spin-out from UCD’s School of Chemistry and Chemical Biology.
Equinome, an equine genomics company, was established to assist the bloodstock industry to maximise the genetic potential of Thoroughbred horses. In 2010 Equinome launched the Equinome Speed Gene Test. This test can be used to predict the optimum racing distance for an individual Thoroughbred by analysing the DNA sequence of a gene related to muscle mass development.
Equinome was co-founded in 2009 as a result of groundbreaking research led Dr Emmeline Hill in UCD’s School of Agriculture, Food Science and Veterinary Medicine, in partnership with Irish racehorse trainer Jim Bolger.
Both companies have been shortlisted in the application of R&D category along with RealView Manufacturing.
Winners in each of the seven award categories will be chosen by an independent panel of judges and announced at an awards ceremony on 2 March. An overall Innovation of the Year Award winner will also be chosen from among the category winners.
Subscribers 0
Fans 0
Followers 0
Followers